Skip to main content

Advertisement

Log in

Imaging features of immune-mediated genitourinary disease

  • Review
  • Published:
Abdominal Radiology Aims and scope Submit manuscript

A Correction to this article was published on 10 May 2019

This article has been updated

Abstract

Purpose

Imaging features of immune-mediated genitourinary diseases often overlap, and the same disease may manifest in different ways, so understanding imaging findings in the context of the patient’s entire clinical picture is important in providing the correct diagnosis.

Methods

In this article, diseases mediated by the immune system which affect the genitourinary system are reviewed. Examples of immune-mediated genitourinary disease including IgG4-related disease, post-transplant lymphoproliferative disorder, immunodeficiency-associated lymphoproliferative disorder due to immunosuppressive and immunomodulatory medications, lymphoma, leukemia, myeloma, amyloidosis, and histiocytosis.

Results

Clinical and imaging features will be presented which may help narrow the differential diagnosis for each disease.

Conclusion

Recognition of immune-related genitourinary disease is important for appropriate medical management as they may mimic other diseases both by imaging and clinical presentation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10
Fig. 11
Fig. 12
Fig. 13
Fig. 14
Fig. 15
Fig. 16

Similar content being viewed by others

Change history

  • 10 May 2019

    The original version of this article was published with a error in the initials of the first, fifth and sixth author name: Jonathon Weber, Frank Miller and Jeanne Horowitz. The correct author's initials should be Jonathon D. Weber, Frank H Miller, and Jeanne M Horowitz. It is now corrected with this correction.

References

  1. Hedgire, S.S., et al., The spectrum of IgG4-related disease in the abdomen and pelvis. AJR Am J Roentgenol, 2013. 201(1): p. 14-22

    Article  PubMed  Google Scholar 

  2. Mann, S., et al., Recognizing IgG4-related tubulointerstitial nephritis. Can J Kidney Health Dis, 2016. 3: p. 34

    Article  PubMed  PubMed Central  Google Scholar 

  3. Della-Torre E, Lanzillotta M., Doglioni C, Immunology of IgG4-related disease. Clin Exp Immunol, 2015. 181(2): p. 191-206

  4. Bledsoe, J.R., et al., IgG4-related disease: review of the histopathologic features, differential diagnosis, and therapeutic approach. APMIS, 2018. 126(6): p. 459-476

    Article  CAS  PubMed  Google Scholar 

  5. Stone, J.H., Y. Zen, and V. Deshpande, IgG4-related disease. N Engl J Med, 2012. 366(6): p. 539-51

    Article  CAS  PubMed  Google Scholar 

  6. Saeki, T., et al., The clinical course of patients with IgG4-related kidney disease. Kidney Int, 2013. 84(4): p. 826-33.

    Article  CAS  PubMed  Google Scholar 

  7. Wallace, Z.S., et al., IgG4-Related Disease: Clinical and Laboratory Features in One Hundred Twenty-Five Patients. Arthritis Rheumatol, 2015. 67(9): p. 2466-75

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Takahashi, N., et al., Renal involvement in patients with autoimmune pancreatitis: CT and MR imaging findings. Radiology, 2007. 242(3): p. 791-801

    Article  PubMed  Google Scholar 

  9. Kim B, Kim J., Byun JH, et al, IgG4-related kidney disease: MRI findings with emphasis on the usefulness of diffusionweighted imaging. Eur J Radiol, 2014. 83: p. 1057-1062.

  10. Maruyama S, Sato Y., Taga A, Emoto I, Shirase T, Haga H, Immunoglobulin G4-related disease presenting as bilateral ovarian masses and mimicking advanced ovarian cancer. J Obstet Gynaecol Res, 2016. 42(1): p. 103-8.

  11. Ohkubo, H., et al., A rare case of IgG4-related disease involving the uterus. Rheumatology (Oxford), 2015. 54(6): p. 1124-5

    Article  CAS  Google Scholar 

  12. Hara, N., et al., The role of naftopidil in the management of benign prostatic hyperplasia. Ther Adv Urol, 2013. 5(2): p. 111-9

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Hara, N., et al., Lower urinary tract symptoms in patients with Niigata Minamata disease: a case-control study 50 years after methyl mercury pollution. Int J Urol, 2013. 20(6): p. 610-5

    Article  CAS  PubMed  Google Scholar 

  14. Migita, K., et al., IgG4-related epididymo-orchitis associated with bladder cancer: possible involvement of BAFF/BAFF-R interaction in IgG4-related urogenital disease. Mod Rheumatol, 2014. 24(1): p. 188-94

    Article  CAS  PubMed  Google Scholar 

  15. Taniguchi, T., et al., A case of multifocal fibrosclerosis involving posterior mediastinal fibrosis, retroperitoneal fibrosis, and a left seminal vesicle with elevated serum IgG4. Hum Pathol, 2006. 37(9): p. 1237-9; author reply 1239.

  16. Zaidan, M., et al., The case mid R: a 69-year-old man with a 10-year history of idiopathic retroperitoneal fibrosis. Kidney Int, 2011. 80(12): p. 1379-80

    Article  PubMed  Google Scholar 

  17. Opelz, G. and R. Henderson, Incidence of non-Hodgkin lymphoma in kidney and heart transplant recipients. Lancet, 1993. 342(8886-8887): p. 1514-6

    Article  CAS  PubMed  Google Scholar 

  18. Opelz, G. and B. Dohler, Lymphomas after solid organ transplantation: a collaborative transplant study report. Am J Transplant, 2004. 4(2): p. 222-30

    Article  PubMed  Google Scholar 

  19. Bhatia S, Ramsay N., Steinbuch M, Dusenbery KE, Shapiro RS, Weisdorf DJ, et al, Malignant neoplasms following bone marrow transplantation. Blood, 1996. 87(9): p. 3633-3639.

  20. Cockfield, S.M., Identifying the patient at risk for post-transplant lymphoproliferative disorder. Transpl Infect Dis, 2001. 3(2): p. 70-8

    Article  CAS  PubMed  Google Scholar 

  21. Loren, A.W., et al., Post-transplant lymphoproliferative disorder: a review. Bone Marrow Transplant, 2003. 31(3): p. 145-55

    Article  CAS  PubMed  Google Scholar 

  22. McDonald, R.A., et al., Incidence of PTLD in pediatric renal transplant recipients receiving basiliximab, calcineurin inhibitor, sirolimus and steroids. Am J Transplant, 2008. 8(5): p. 984-9

    Article  CAS  PubMed  Google Scholar 

  23. Shapiro, R., et al., Posttransplant lymphoproliferative disorders in adult and pediatric renal transplant patients receiving tacrolimus-based immunosuppression. Transplantation, 1999. 68(12): p. 1851-4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Dharnidharka, V.R., CComprehensive Review of Post-Organ Transplant Hematologic Cancers. Am J Transplant, 2017

  25. Quinlan, S.C., et al., Risk factors for early-onset and late-onset post-transplant lymphoproliferative disorder in kidney recipients in the United States. Am J Hematol, 2011. 86(2): p. 206-9

    Article  PubMed  PubMed Central  Google Scholar 

  26. Al-Mansour, Z., B.P. Nelson, and A.M. Evens, Post-transplant lymphoproliferative disease (PTLD): risk factors, diagnosis, and current treatment strategies. Curr Hematol Malig Rep, 2013. 8(3): p. 173-83

    Article  PubMed  PubMed Central  Google Scholar 

  27. Katabathina, V., et al., Complications of Immunosuppressive Therapy in Solid Organ Transplantation. Radiol Clin North Am, 2016. 542): p. 303-19

    Article  PubMed  Google Scholar 

  28. Scarsbrook, A.F., et al., Post-transplantation lymphoproliferative disorder: the spectrum of imaging appearances. Clin Radiol, 2005. 60(1): p. 47-55

    Article  CAS  PubMed  Google Scholar 

  29. Vrachliotis, T.G., et al., CT findings in posttransplantation lymphoproliferative disorder of renal transplants. AJR Am J Roentgenol, 2000. 175(1): p. 183-8

    Article  CAS  PubMed  Google Scholar 

  30. R. Lopez-Ben, J.K.S., C.E. Kew II, et al., Focal posttransplantation lymphoproliferative disorder at renal allograft hilum. AJR Am J Roentgenol, 2000. 175: p. 1417-1422.

  31. Metser, U. and G. Lo, FDG-PET/CT in abdominal post-transplant lymphoproliferative disease. Br J Radiol, 2016. 89(1057): p. 20150844

    Article  PubMed  Google Scholar 

  32. Barrington, S.F., et al., Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group. J Clin Oncol, 2014. 32(27): p. 3048-58.

  33. Vali R, P.A., Bajno L, Moineddin R, Shammas A., The value of 18F-FDG PET in pediatric patients with post-transplant lymphoproliferative disorder at initial diagnosis. Pediatr Transplant, 2015. 19(8): p. 932-9.

  34. Vali R, Punnett A., Bajno L, Moineddin R, Shammas A., The value of 18F-FDG PET in pediatric patients with post-transplant lymphoproliferative disorder at initial diagnosis. Pediatr Transplant, 2015. 19(8): p. 932-9

    Article  CAS  PubMed  Google Scholar 

  35. Inoue T, S. Satoh, Saito M, Horikawa Y, Tsuchiya N, Habuchi T, Post-transplant lymphoproliferative disorder involving the ovary as an initial manifestation: a case report. Journal of Medical Case Reports., 2010(4): p. 184.

  36. Loo, E.Y., et al., Classical Hodgkin lymphoma arising in the setting of iatrogenic immunodeficiency: a clinicopathologic study of 10 cases. Am J Surg Pathol, 2013. 37(8): p. 1290-7

    Article  PubMed  Google Scholar 

  37. Kubica, M.G. and N.A. Sangle, Latrogenic immunodeficiency-associated lymphoproliferative disorders in transplant and nontransplant settings. Indian J Pathol Microbiol, 2016. 59(1): p. 6-15

    PubMed  Google Scholar 

  38. Kamel OW (1997) Iatrogenic lymphoproliferative disorders in nontransplantation settings. Semin Diagn Pathol 14(1):27–34

    CAS  PubMed  Google Scholar 

  39. Ohkura Y, S.J., Haruta S, et al., Primary Adrenal Lymphoma Possibly Associated With Epstein-Barr Virus Reactivation Due to Immunosuppression Under Methotrexate Therapy. Medicine, 2015. 94(31): p. 1270.

  40. Key Statistics for Non-Hodgkin’s Lymphoma. 2018 [cited 2019 1/4/2019]; Available from: https://www.cancer.org/cancer/non-hodgkin-lymphoma/about/key-statistics.html.

  41. Chen L, Richendollar B., Bunting S, Campbell S, Zhou M., Lymphomas and lymphoproliferative disorders clinically presenting as renal carcinoma: a clinicopathological study of 14 cases. Pathology, 2013. 45(7): p. 756-53.

  42. Sandrasegaran, K., et al., Imaging features of haematological malignancies of kidneys. Clin Radiol, 2016. 71(3): p. 195-202

    Article  CAS  PubMed  Google Scholar 

  43. Bach, A.G., et al., Prevalence and patterns of renal involvement in imaging of malignant lymphoproliferative diseases. Acta Radiol, 2012. 53(3): p. 343-8

    Article  PubMed  Google Scholar 

  44. Sheth S, Ali S., Fishman E., Imaging of renal lymphoma: patterns of disease with pathologic correlation. Radiographics, 2006. 26(4): p. 1151-1168.

  45. Emad-Eldin S, Rakha S., Hanna AZ, Badawy H, Usefulness of diffusion-weighted magnetic resonance imaging for the characterization of benign and malignant renal lesions. The Egyptian Journal of Radiology and Nuclear Medicine, 2015. 47: p. 325-333.

  46. Dai, Z., et al., Primary follicular non-Hodgkin's lymphoma of the ureter: A case report and literature review. Oncol Lett, 2016. 11(6): p. 3939-3942

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. Ni, B.W., et al., Malignant lymphoma of the ureter: A case report and literature review. Exp Ther Med, 2014. 7(6): p. 1521-1524

    Article  PubMed  PubMed Central  Google Scholar 

  48. Crasta JA, Vallikad E., Ovarian Lymphoma. Indian J Med Pediatr Oncol, 2009. 30(1): p. 28-30

  49. Zhou, L., et al., Primary adrenal lymphoma: radiological; pathological, clinical correlation. Eur J Radiol, 2012. 81(3): p. 401-5

    Article  PubMed  Google Scholar 

  50. Thakore P, A.S., Turner C, Vaslyeva T, Acute Lymphocytic Leukemia with Bilateral Renal Masses Masquerading as Nephroblastomatosis. Case reports in pediatrics, 2015. 2015.

  51. Luciano, R.L. and U.C. Brewster, Kidney involvement in leukemia and lymphoma. Adv Chronic Kidney Dis, 2014. 21(1): p. 27-35

    Article  PubMed  Google Scholar 

  52. Lanore, J.J., et al., Hemodialysis for acute renal failure in patients with hematologic malignancies. Crit Care Med, 1991. 19(3): p. 346-51

    Article  CAS  PubMed  Google Scholar 

  53. Richmond, J., et al., Renal lesions associated with malignant lymphomas. Am J Med, 1962. 32: p. 184-207

    Article  CAS  PubMed  Google Scholar 

  54. Araki, T., Leukemic involvement of the kidney in children: CT features. J Comput Assist Tomogr, 1982. 6(4): p. 781-4

    Article  CAS  PubMed  Google Scholar 

  55. Greenstein, F., et al., Ureteral obstruction from isolated focus of chronic lymphocytic leukemia. Urology, 1984. 24(1): p. 70-2

    Article  CAS  PubMed  Google Scholar 

  56. Bogdan, C.A., et al., Chronic lymphocytic leukemia with prostate infiltration mediated by specific clonal membrane-bound IgM. Cancer Res, 2003. 63(9): p. 2067-71

    CAS  PubMed  Google Scholar 

  57. Mazzu, D., R.B. Jeffrey, Jr., and P.W. Ralls, Lymphoma and leukemia involving the testicles: findings on gray-scale and color Doppler sonography. AJR Am J Roentgenol, 1995. 164(3): p. 645-7

    Article  CAS  PubMed  Google Scholar 

  58. Geetha N, Lali V., Mathews A, Prakash NP., Acute lymphoblastic leukaemia presenting with a uterine cervical mass. Clin Cancer Investig J, 2015. 4: p. 280-281.

  59. Oliva E, Ferry J., Young RH, Prat J, Srigley JR, Scully RE, Granulocytic sarcoma of the female genital tract: A clinicopathologic study of 11 cases. Am J Surg Pathol, 1997. 21: p. 1156-65.

  60. Valbuena, J.R., et al., Myeloid sarcoma involving the testis. Am J Clin Pathol, 2005. 124(3): p. 445-52

    Article  PubMed  Google Scholar 

  61. Zago, L.B., et al., Testicular myeloid sarcoma: case report. Rev Bras Hematol Hemoter, 2013. 35(1): p. 68-70

    Article  PubMed  PubMed Central  Google Scholar 

  62. Rajkumar, S.V., Updated Diagnostic Criteria and Staging System for Multiple Myeloma. Am Soc Clin Oncol Educ Book, 2016. 35: p. e418-23

    Article  PubMed  Google Scholar 

  63. Oshima, K., et al., Clinical and pathologic findings in 52 consecutively autopsied cases with multiple myeloma. Am J Hematol, 2001. 67(1): p. 1-5

    Article  CAS  PubMed  Google Scholar 

  64. Philips, S., et al., Abdominal manifestations of extraosseous myeloma: cross-sectional imaging spectrum. J Comput Assist Tomogr, 2012. 36(2): p. 207-12

    Article  PubMed  Google Scholar 

  65. Kapadia, S.B., Multiple myeloma: a clinicopathologic study of 62 consecutively autopsied cases. Medicine (Baltimore), 1980. 59(5): p. 380-92

    Article  CAS  Google Scholar 

  66. Birjawi, G.A., et al., Abdominal manifestations of multiple myeloma: a retrospective radiologic overview. Clin Lymphoma Myeloma, 2008. 8(6): p. 348-51

    Article  PubMed  Google Scholar 

  67. IIgel, T.C., et al., Renal plasmacytoma: Mayo Clinic experience and review of the literature. Urology, 1991. 37(4): p. 385-9

    Article  CAS  PubMed  Google Scholar 

  68. Sedlic, A., et al., Abdominal extraosseous lesions of multiple myeloma: imaging findings. Can Assoc Radiol J, 2014. 65(1): p. 2-8

    Article  PubMed  Google Scholar 

  69. Yang, G. F., Zhu, H., Zhang, L. J., & Lu, G. M, Primary renal plasmacytoma: Case report and literature review. J Cancer Res Exp Oncol., 2009. 2

    Google Scholar 

  70. Sered, S. and P. Nikolaidis, CT findings of perirenal plasmacytoma. AJR Am J Roentgenol, 2003. 181(3): p. 888

    Article  PubMed  Google Scholar 

  71. Li, Y., et al., Beyond Prostate Adenocarcinoma: Expanding the Differential Diagnosis in Prostate Pathologic Conditions. Radiographics, 2016. 36(4): p. 1055-75

    Article  PubMed  Google Scholar 

  72. Mimura, R., et al., Extramedullary plasmacytoma involving perirenal space accompanied by extramedullary hematopoiesis and amyloid deposition. Japanese Journal of Radiology, 2010. 28(4): p. 309-13

    Article  PubMed  Google Scholar 

  73. Jinzaki, M., et al., Role of computed tomography urography in the clinical evaluation of upper tract urothelial carcinoma. International Journal of Urology, 2016. 23(4): p. 284-98

    Article  PubMed  Google Scholar 

  74. Fitzpatrick, R., et al., Primary amyloidosis of the bladder; a mimicker of bladder cancer. Canadian Journal of Urology, 2017. 24(3): p. 8868-8870

    PubMed  Google Scholar 

  75. Levine, E., Abdominal visceral calcification in secondary amyloidosis: CT findings. Abdom Imaging, 1994. 19(6): p. 554-5

    Article  CAS  PubMed  Google Scholar 

  76. Kim, B., et al., Imaging of the seminal vesicle and vas deferens. Radiographics, 2009. 29(4): p. 1105-21

    Article  PubMed  Google Scholar 

  77. Stephens, M., et al., Intense Uptake in Amyloidosis of the Seminal Vesicles on 68Ga-PSMA PET Mimicking Locally Advanced Prostate Cancer. Clinical Nuclear Medicine, 2017. 42(2): p. 147-148

    Article  PubMed  Google Scholar 

  78. Ogawa, Y., M. Nakagawa, and S. Ikeda, Prostate amyloid tumor is a clue leading to the diagnosis of systemic AL amyloidosis. Amyloid, 2013. 20(3): p. 193-4

    Article  PubMed  Google Scholar 

  79. Casella, R., et al., Primary testicular amyloidosis mimicking tumor in a cryptorchid testis. Urology, 2002. 59(3): p. 445

    Article  PubMed  Google Scholar 

  80. Winkler, D.D., J.A. Emery, and C.B. Alan, Amyloidosis of the endometrium: an asymptomatic presentation. Obstetrics & Gynecology, 2004. 104(5 Pt 2): p. 1144-7

    Article  Google Scholar 

  81. Mar, W.A., et al., Rosai–Dorfman Disease: Manifestations Outside of the Head and Neck. AJR Am J Roentgenol, 2017. 208(4): p. 721-732

    Article  PubMed  Google Scholar 

  82. Brown, W.E., F.V. Coakley, and M. Heaney, Renal involvement by Rosai–Dorfman disease: CT findings. Abdom Imaging, 2002. 27(2): p. 214-6

    Article  CAS  PubMed  Google Scholar 

  83. Rodriguez Torres, C., et al., Rosai–Dorfman disease with atypical intrascrotal involvement. Int J Urol, 2015. 22(8): p. 794-6

    Article  PubMed  Google Scholar 

  84. Alberti, N., et al., Erdheim–Chester disease: a rare diagnosis with evocative imaging. Diagnostic and Interventional Imaging, 2013. 94(4): p. 457-9

    Article  CAS  PubMed  Google Scholar 

  85. Arnaud, L., et al., Systemic perturbation of cytokine and chemokine networks in Erdheim–Chester disease: a single-center series of 37 patients. Blood, 2011. 117(10): p. 2783-90

    Article  CAS  PubMed  Google Scholar 

  86. Balink, H., et al., Scintigraphic diagnosis of Erdheim–Chester disease. Journal of Clinical Oncology, 2011. 29(16): p. e470-2

    Article  PubMed  Google Scholar 

  87. Yun, E.J., et al., Erdheim–Chester disease: case report and review of associated urological, radiological and histological features. Journal of Urology, 2003. 169(4): p. 1470-1

    Article  PubMed  Google Scholar 

  88. Courtillot, C., et al., Endocrine Manifestations in a Monocentric Cohort of 64 Patients With Erdheim–Chester Disease. Journal of Clinical Endocrinology & Metabolism, 2016. 101(1): p. 305-13

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jonathon Weber.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Weber, J., Hammond, N., Yaghmai, V. et al. Imaging features of immune-mediated genitourinary disease. Abdom Radiol 44, 2217–2232 (2019). https://doi.org/10.1007/s00261-019-01946-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00261-019-01946-z

Keywords

Navigation